Menu
GeneBe

3-158732298-A-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PM2BP4_Strong

The NM_206963.2(RARRES1):c.118T>G(p.Ser40Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000149 in 1,343,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 8.4e-7 ( 0 hom. )

Consequence

RARRES1
NM_206963.2 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.260
Variant links:
Genes affected
RARRES1 (HGNC:9867): (retinoic acid receptor responder 1) This gene was identified as a retinoid acid (RA) receptor-responsive gene. It encodes a type 1 membrane protein. The expression of this gene is upregulated by tazarotene as well as by retinoic acid receptors. The expression of this gene is found to be downregulated in prostate cancer, which is caused by the methylation of its promoter and CpG island. Alternatively spliced transcript variant encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]
MFSD1 (HGNC:25874): (major facilitator superfamily domain containing 1) Predicted to enable protein homodimerization activity. Predicted to be involved in protein localization to lysosome and protein stabilization. Predicted to be located in lysosome. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM1
In a glycosylation_site O-linked (Xyl...) (chondroitin sulfate) serine (size 0) in uniprot entity TIG1_HUMAN
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.053441435).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RARRES1NM_206963.2 linkuse as main transcriptc.118T>G p.Ser40Ala missense_variant 1/6 ENST00000237696.10
RARRES1NM_002888.4 linkuse as main transcriptc.118T>G p.Ser40Ala missense_variant 1/4
RARRES1XM_005247686.6 linkuse as main transcriptc.118T>G p.Ser40Ala missense_variant 1/6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RARRES1ENST00000237696.10 linkuse as main transcriptc.118T>G p.Ser40Ala missense_variant 1/61 NM_206963.2 P1P49788-1
ENST00000465477.5 linkuse as main transcript upstream_gene_variant 5

Frequencies

GnomAD3 genomes
AF:
0.00000661
AC:
1
AN:
151262
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000245
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
8.39e-7
AC:
1
AN:
1191740
Hom.:
0
Cov.:
37
AF XY:
0.00000173
AC XY:
1
AN XY:
578166
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000101
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000661
AC:
1
AN:
151262
Hom.:
0
Cov.:
33
AF XY:
0.0000135
AC XY:
1
AN XY:
73918
show subpopulations
Gnomad4 AFR
AF:
0.0000245
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 09, 2021The c.118T>G (p.S40A) alteration is located in exon 1 (coding exon 1) of the RARRES1 gene. This alteration results from a T to G substitution at nucleotide position 118, causing the serine (S) at amino acid position 40 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.73
Cadd
Benign
3.9
Dann
Benign
0.46
DEOGEN2
Benign
0.0021
T;.
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.0046
N
LIST_S2
Benign
0.17
T;T
M_CAP
Benign
0.0075
T
MetaRNN
Benign
0.053
T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
0.69
N;N
MutationTaster
Benign
1.0
N;N
PrimateAI
Uncertain
0.74
T
PROVEAN
Benign
-0.31
N;N
REVEL
Benign
0.0060
Sift
Benign
0.45
T;T
Sift4G
Benign
0.64
T;T
Polyphen
0.0
B;B
Vest4
0.061
MutPred
0.20
Loss of glycosylation at S40 (P = 5e-04);Loss of glycosylation at S40 (P = 5e-04);
MVP
0.095
MPC
0.43
ClinPred
0.044
T
GERP RS
-5.6
Varity_R
0.061
gMVP
0.11

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1194657718; hg19: chr3-158450087; API